Rapt Therapeutics (RAPT) PT Lowered to $13 at Barclays
Tweet
Share
E-mailGet Alerts RAPT Hot Sheet
Price: $58.02 --0%
Rating Summary:
7 Buy, 13 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 20
Rating Summary:
7 Buy, 13 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 20
Join SI Premium – FREE
Barclays analyst Leon Wang lowered the price target on Rapt Therapeutics (NASDAQ: RAPT) to $13.00 (from $35.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Alpha Cognition Inc (ACOG) PT Raised to $20 at H.C. Wainwright
- Affin Bank Bhd. (ABANK:MK) PT Lowered to MYR2.40 at Nomura/Instinet
- Artivion Inc. (AORT) PT Raised to $40 at Canaccord
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
